FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB – A TRANSITION LEADING TO CHANGES?

Maria José Temido  1     Andrea Emília Pereira Silva     Mafalda João  2     Raquel Pimentel     Catarina Correia     Sandra Lopes     Sofia Mendes     Pedro Narra Figueiredo     Francisco Silva Portela    
1 Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 Portuguese Oncology Institute of Coimbra, Coimbra, Portugal

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing